HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Gus J. Vlahakes Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mangoni, A. A. Articles by Fifer, M. A. Search for Related Content PubMed PubMed Citation Articles by Mangoni, A. A. Articles by Fifer, M. A. Related Collections Valve disease

Eur J Cardiothorac Surg 2001;19:68-73
© 2001 Elsevier Science NL

Outcome following isolated tricuspid valve replacement

^a Department of Medicine (Cardiology Division), Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
^b Department of Surgery (Cardiac Surgical Division), Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

Received 8 June 2000; received in revised form 8 October 2000; accepted 17 October 2000.

Corresponding author. Tel.: +1-617-726-1832; fax: +1-617-726-5988
e-mail: mfifer{at}partners.org

Objectives: The clinical outcome of isolated tricuspid valve replacement is not well defined because this procedure is usually performed concomitantly with other valve surgery. Methods: We retrospectively studied the short and long-term outcome of 15 consecutive patients (six men and nine women, aged 61±3 years) undergoing isolated tricuspid valve replacement from 1984 to 1996. The cause of valve dysfunction was rheumatic heart disease in 12 patients, healed endocarditis in two patients, and sarcoidosis in one patient. The tricuspid valve was stenotic in one patient, regurgitant in eight patients, and both stenotic and regurgitant in six patients. A St. Jude Medical prosthesis was placed in eight patients, Carpentier–Edwards in five patients, and Björk–Shiley and Starr–Edwards in one patient each. Results: The median survival was only 1.2 years. Three patients (20%) died 30 days after the surgery or before discharge, and six other patients (40%) died within 3 years of surgery. Anasarca was the only predictor of short-term mortality (P=0.03), while the predictors of long-term mortality were anemia (P=0.01), rheumatic heart disease (P=0.04), previous stroke (P=0.04), and previous mitral valve surgery (P=0.04). Conclusions: Isolated tricuspid valve replacement is characterized by a poor short and long-term outcome.

Key Words: Heart valve surgery • Tricuspid regurgitation • Tricuspid stenosis • Tricuspid valve

This article has been cited by other articles:

				S. Tokunaga, M. Masuda, A. Shiose, Y. Tomita, S. Morita, and R. Tominaga Long-Term Results of Isolated Tricuspid Valve Replacement Asian Cardiovasc Thorac Ann, February 1, 2008; 16(1): 25 - 28. [Abstract] [Full Text] [PDF]

				N. A G Solomon, R. C H Lim, P. Nand, and K. J Graham Tricuspid Valve Replacement: Bioprosthetic or Mechanical Valve? Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 143 - 148. [Abstract] [Full Text] [PDF]

				M. Carrier, Y. Hebert, M. Pellerin, D. Bouchard, L. P. Perrault, R. Cartier, A. Basmajian, P. Page, and N. C. Poirier Tricuspid valve replacement: an analysis of 25 years of experience at a single center Ann. Thorac. Surg., January 1, 2003; 75(1): 47 - 50. [Abstract] [Full Text] [PDF]